Yahoo Finance’s Brian Sozzi and Emily McCormick speak with Minute Media CEO, Asaf Peled, about the company’s expansion, sports betting, outlook for going public, and more.
Pfizer and BioNTech on Monday said trial results showed their coronavirus vaccine is safe and produces a robust immune response in children aged five to 11, adding that they would seek regulatory approval shortly.
Meg Fitzgerald, “Ascending Davos” Author and Columbia University Healthcare Policy Professor, joins Yahoo Finance Live to discuss the future of vaccines, the FDA rejecting Pfizer's booster shot for the general public and the importance of getting young children vaccinated as soon as possible.
Yahoo Finance’s Brian Sozzi and Emily McCormick speak with Deutsche Bank Analyst, Edison Yu, about the company’s take on Rocket Labs after initiating it with a buy rating and an $18 price target.
Yahoo Finance's Brian Sozzi and Emily McCormick break down which stocks they're keeping a close eye on during Monday's sell-off.
Il sesso a pagamento "in sicurezza" è l’opzione di prima scelta in era Covid. Clienti ed escort non rinunciano agli incontri, ma entrambe le parti vogliono essere sicure di non essere a rischio contagio da Coronavirus. È quanto emerge da un sondaggio condotto da Escort Advisor, il primo sito di recensioni di escort in Europa, che ha indagato i comportamenti dei clienti del sesso a pagamento durante la pandemia.
The Supreme Court issued notice to the Centre on the plea of Delhi Commission for Protection of Child Rights (DCPCR) and sought its response within two weeks.
Pfizer said Monday its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon — a key step toward beginning vaccinations for youngsters. The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older. For elementary school-aged kids, Pfizer tested a much lower dose — a third of the amount that’s in each shot given now.
Powecom is one of the only KN95 mask brands recommended by the FDA.
Coronavirus Live Updates: India reported 30,256 fresh cases of Covid-19, 43,938 recoveries, and 295 deaths in the last 24 hours.
The National Institutes of Health director says a government advisory panel’s decision to limit Pfizer COVID-19 booster shots to Americans 65 and older as well as those at high risk of severe disease is a preliminary step and predicts broader approval for most Americans “in the next few weeks.” Dr. Francis Collins told “Fox News Sunday” that the panel’s recommendation Friday was correct based on a “snapshot” of available data on the effectiveness of Pfizer’s two-shot regimen over time. Collins, who also appeared on CBS’ “Face the Nation,” said: “I think there will be a decision in the coming weeks to extend boosters beyond the list that they approved on Friday.”
Coverage for low-income people locked out of Medicaid by ideological battles. The $3.5 trillion domestic agenda bill touches almost all aspects of American life, from taxes to climate change, but the health care components are a cornerstone for Democrats, amplified during the COVID-19 crisis. For the nearly 145 million Americans covered by government health programs, along with their families and communities, the investment in the nation's services could make a difference in the quality of life for decades.
The Belgian town of Aarschot has a vaccination rate of 94% of all adults, but Mayor Gwendolyn Rutten worries her town is too close for comfort to the capital of Brussels, where the rate stands at 63%. “Otherwise, you drag all others back into danger,” Rutten said in a recent interview. President Biden announced mandates last week that cover large portions of the population, sometimes without any option to test instead.
Just one month ago, President Joe Biden and his health advisers announced big plans to soon deliver a booster shot of the coronavirus vaccine to all Americans. But after campaigning for the White House on a pledge to “follow the science,” Biden found himself uncharacteristically ahead of it with that lofty pronouncement. A key government advisory panel overwhelmingly rejected Biden's plan to give COVID-19 booster shots across the board and instead recommended the extra vaccine dose only for those who are age 65 or older or who run a high risk of severe disease. “The plan is for every adult to get a booster shot eight months after you got your second shot,” Biden said, noting that his administration would be ready to begin the program on Sept. 20.
Nearly three-quarters of vaccinated Americans say they would get a booster if it were available to them, according to a new Yahoo News/YouGov poll — a number that holds across nearly every age group and not just among older, more vulnerable Americans.
Exhausted nurses in the Philippines are struggling to care for patients as colleagues contract Covid-19 or quit a profession that was dangerously understaffed even before the pandemic.
A federal advisory panel voted Friday not to recommend booster shots for every American 16 or older who has already been vaccinated against the coronavirus, only to vote minutes later to approve boosters for people 65 and older, as well as those at high risk.
American Hotel & Lodging Association President and CEO Chip Rogers joins the Yahoo Finance Live panel to discuss the latest hospitality trends amid COVID-19.
As the spread of the delta variant continues unabated in much of the U.S., public health leaders have approved health care rationing in Idaho and parts of Alaska and Montana. At least five more states — Georgia, Kentucky, Mississippi, Arkansas and Texas — are nearing capacity with more than 90% of their intensive care unit beds full, according to data from the U.S. Department of Health and Human Services. The move to ration healthcare comes amid a spike in the number of unvaccinated COVID-19 patients requiring hospitalization.
Bill Westerman, Vice President of Product Management at CalAmp, joined Yahoo Finance Live to discuss the Bus Guardian and how it is helping school with contact tracing during the new school year.